Insulin Degludec
TRESIBA
Insulin Analog
NADAC/unit
$9.0250
No Shortage
Tier 1: 17.3%
PA Req: 0.9%
Insulin Degludec replaces or supplements natural insulin to control blood sugar in diabetes.
vs. brand TRESIBA: Generic saves up to 10% per unit
Active Shortages
2025-07-21 Unbranded Insulin Degludec 3 mL U-100 FlexTouch® will continue to be shipped to wholesalers while supplies last, up until the discontinuation dates. Full discontinuation will occur on December 31, 2025., Novo Nordisk, Inc.
2025-07-21 Unbranded Insulin Degludec 10 mL vial will continue to be shipped to wholesalers while supplies last, up until the discontinuation dates. Full discontinuation will occur on December 31, 2025., Novo Nordisk, Inc.
2025-07-21 Unbranded Insulin Degludec 3 mL U-200 FlexTouch® will continue to be shipped to wholesalers while supplies last, up until the discontinuation dates. Full discontinuation will occur on December 31, 2025., Novo Nordisk, Inc.
Explore in the Ecosystem
Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.